---
title: "TRUEX SAMANTHA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/7de2e114-4f57-517f-9277-de4e8ef66348
json: https://whiteintel.dev/api/public/dossier/7de2e114-4f57-517f-9277-de4e8ef66348
identifier: sec:0002017156
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# TRUEX SAMANTHA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002017156`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/7de2e114-4f57-517f-9277-de4e8ef66348  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/7de2e114-4f57-517f-9277-de4e8ef66348  

## Ownership & control

### Holdings / subsidiaries

- **Avalo Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/7ab53ad5-4202-5e5d-afb7-054c499320ac

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **TRUEX SAMANTHA**. Human view: https://whiteintel.dev/entity/7de2e114-4f57-517f-9277-de4e8ef66348 · Structured JSON: https://whiteintel.dev/api/public/dossier/7de2e114-4f57-517f-9277-de4e8ef66348._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._